Cargando…
MicroRNAs in sputum specimen as noninvasive biomarkers for the diagnosis of nonsmall cell lung cancer: An updated meta-analysis
BACKGROUND: Nonsmall cell lung cancer (NSCLC) is a serious leading cause of death worldwide. Recently, multiple researches have identified that microRNA (miRNA) in sputum could be a useful tool for NSCLC diagnosis. The objective of this study was to assess whether aberrant miRNA expression could be...
Autores principales: | Zhang, Xiaoyun, Wang, Qian, Zhang, Shijie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380860/ https://www.ncbi.nlm.nih.gov/pubmed/30732158 http://dx.doi.org/10.1097/MD.0000000000014337 |
Ejemplares similares
-
MicroRNA-155 from sputum as noninvasive biomarker for diagnosis of active pulmonary tuberculosis
por: Ying, Hua, et al.
Publicado: (2020) -
Serum microRNAs as Biomarkers for the Noninvasive Early Diagnosis of Biliary Tract Cancer
por: Han, Yueting, et al.
Publicado: (2021) -
A meta‐analysis: microRNAs’ prognostic function in patients with nonsmall cell lung cancer
por: Yu, Na, et al.
Publicado: (2017) -
Plasma MicroRNAs as Potential Noninvasive Biomarkers for In-Stent Restenosis
por: He, Meijiao, et al.
Publicado: (2014) -
Extracellular MicroRNAs as Intercellular Mediators and Noninvasive Biomarkers of Cancer
por: Ortiz-Quintero, Blanca
Publicado: (2020)